OpenAI is throwing everything into building a fully automated researcher

March 20, 2026
OpenAI is refocusing its research efforts and throwing its resources into a new grand challenge. The San Francisco firm has set its sights on building what it calls an AI researcher, a fully automated agent-based system that will be able to go off and tackle large, complex problems by itself. ​​OpenAI says that the new…

Mind-altering substances are (still) falling short in clinical trials

March 20, 2026
This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made the leap from counterculture to major focus of clinical research. Compounds like psilocybin—which is found in magic mushrooms—are being explored for all sorts of health applications, including treatments for depression, PTSD, addiction, and even obesity. Over…